About Instil Bio (TIL)
Instil Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a cell therapy pipeline of autologous tumor-infiltrating lymphocyte (TIL) therapies for the treatment of patients with cancer. TIL therapies leverage... Read more
- USD18.40
- USD26.40
- USD18.40
- USD92.00
- 1.40%
- --
- 1.35M
- 204.30k
- 96M
- 9.62
- 45.20%
Stock News
58 minutes ago
Alphabet’s stock is charging even higher. Here’s how Google’s AI bets are resonating.
MarketWatch
2 hours ago
Stocks bounce back, and Honeywell's buying spree continues
CNBC
2 hours ago
American Airlines CFO says some travelers are avoiding Newark airport
CNBC
2 hours ago
Ray Dalio says to fear the bond market as deficit becomes critical
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
